Peter Grinspoon

Last updated
Peter Grinspoon
Dr. Peter Grinspoon.jpg
Born1966 (age 5758)
OccupationPhysician
Employers
Parent
Relatives David Grinspoon (brother)

Peter Grinspoon (born 1966) is an American physician. He is an internist and medical cannabis specialist at Massachusetts General Hospital and an instructor at Harvard Medical School. He is an expert on the topic of medical and recreational cannabis, and also has a strong interest in the areas of physician health, addiction and recovery, and in psychedelic treatments. He is a certified physician coach for the MGH Center for Physician Well Being as well as a Health and Wellness Coach. His 2016 book Free Refills: A Doctor Confronts His Addiction describes recovery from an opiate addiction from his perspective as a physician. [1]

Contents

His subsequent book, Seeing Through the Smoke: A Cannabis Expert Untangles the Truth About Marijuana, features a foreward written by Dr. Andrew Weil. He has appeared on national television programs including The Daily Show,Good Morning America,CBS Mornings,Fox and Friends,Fox Nation,NBC Nightly News,MSNBC and C-SPAN2 [2] to discuss drug policy, cannabis legalization as well as his addiction and recovery. He served as an Associate Director for Massachusetts Physician Health Service, part of the Massachusetts Medical Society from 2013 to 2015, helping and advocating for other physicians who struggle with addiction. [3]

Grinspoon is also a contributing editor to Harvard Health Publications. [4]

He is a board member of the advocacy group Doctors For Cannabis Regulation and speaks internationally on various cannabis-related issues. [5] He is frequently cited in the popular press, and has been noted in USA Today, The Washington Post, The New York Times, The Wall Street Journal, People Magazine, [6] NY Magazine, [7] The Daily Beast, and The Boston Globe. [8]

He has also appeared on numerous podcasts and radio programs. He was featured on NPR's All Things Considered in a piece about the harmfulness of withholding medication assisted treatment for opioid use disorders from physicians.[ citation needed ]

Early life and career

Grinspoon is the son of famous cannabis activist Lester Grinspoon and the brother of respected planetary scientist and popular writer David Grinspoon. He is the nephew of billionaire philanthropist Harold Grinspoon. He grew up in Wellesley, Massachusetts, with a twin brother Joshua, his older brother David, and another older brother Danny, who died at the age of 16 from leukemia. Danny's struggle with leukemia has been documented in the popular press as medical cannabis was vitally helpful to him and Danny's parents were forced to procure cannabis illegally for him during Nixon's War on Cannabis. [9]

Grinspoon graduated from Swarthmore College with Honors in Philosophy and then went to work for Greenpeace for five years before enrolling in medical school. At Greenpeace, he wrote an influential piece in The Nation titled, "Atom and Eve: A Love Story" based on leaked documents from the nuclear industry. He also was instrumental in one of Greenpeace's most high-profile protests, the successful stoppage of a Trident 2 nuclear missile test. [10]

In 1993, Grinspoon entered Boston University School of Medicine, graduating with Honors. From 1997 to 2000 He trained at Harvard's Brigham and Women's Hospital, in the Primary Care Medical Residency, giving his senior presentation on medical cannabis.[ citation needed ]

Additional activities

Grinspoon was a consultant to the 2018 production of Jagged Little Pill at the American Repertory Theater. [11] He was a contributor to Harvard's online course OpioidX: The Opioid Crisis in America.[ citation needed ] He was one of the featured members of the Boston Resilient Exhibit, which honored Boston-area leaders in the fight against addiction. [12] [ failed verification ] He served as an expert witness at the lawsuit successfully challenging the ban against vaping cannabis in Massachusetts in 2019.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Recreational drug use</span> Use of drugs with the primary intention to alter the state of consciousness

Recreational drug use is the use of one or more psychoactive drugs to induce an altered state of consciousness, either for pleasure or for some other casual purpose or pastime. When a psychoactive drug enters the user's body, it induces an intoxicating effect. Recreational drugs are commonly divided into three categories: depressants, stimulants, and hallucinogens.

<span class="mw-page-title-main">Medical cannabis</span> Marijuana used medicinally

Medical cannabis, or medical marijuana (MMJ), is cannabis and cannabinoids that are prescribed by physicians for their patients. The use of cannabis as medicine has not been rigorously tested due to production and governmental restrictions, resulting in limited clinical research to define the safety and efficacy of using cannabis to treat diseases.

<span class="mw-page-title-main">Patrick J. Kennedy</span> American politician (born 1967)

Patrick Joseph Kennedy II is an American retired politician and mental health advocate. From 1995 to 2011, he served as a Democratic member of the United States House of Representatives from Rhode Island's 1st congressional district, and was the first Generation X member of congress when he was elected in 1995. He is a former member of the Opioid and Drug Abuse Commission and a co-founder of One Mind, a mental health nonprofit.

The New England Journal of Medicine (NEJM) is a weekly medical journal published by the Massachusetts Medical Society. It has been described as being among the most prestigious peer-reviewed medical journals as well as being the oldest continuously published one.

The Canadian Medical Association is a national, voluntary association of physicians and medical learners that advocates on national health matters. Its primary mandate is to drive positive change in health care by advocating on key health issues facing doctors and their patients.

<span class="mw-page-title-main">Massachusetts General Hospital</span> Hospital in Massachusetts, United States

Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School, Harvard University located in the West End neighborhood of Boston, Massachusetts. Massachusetts General Hospital houses the world's largest hospital-based research program, the Mass General Research Institute, with an annual research budget of more than $1.2 billion in 2021. It is the third-oldest general hospital in the United States with a patient capacity of 999 beds. Along with Brigham and Women's Hospital, Mass General is a founding member of Mass General Brigham, formerly known as Partners HealthCare, the largest healthcare provider in Massachusetts.

<span class="mw-page-title-main">Christopher Lawford</span> American author, actor, and activist (1955–2018)

Christopher Kennedy Lawford was an American author, actor, and activist. He was a member of the prominent Kennedy family, and son of English actor Peter Lawford and Patricia "Pat" Kennedy Lawford, who was a sister of President John F. Kennedy. He graduated from Tufts University in 1977 and earned a Juris Doctor degree from Boston College in 1983. He later earned a master's certificate in Clinical Psychology from Harvard University and was a lecturer on drug addiction.

The Multidisciplinary Association for Psychedelic Studies (MAPS) is an American nonprofit organization working to raise awareness and understanding of psychedelic substances. MAPS was founded in 1986 by Rick Doblin and is now based in San Jose, California.

Lester Grinspoon was an American psychiatrist and long-standing associate professor of psychiatry at Harvard Medical School best known for his groundbreaking works on the science and social policy of cannabis, psychedelics and other drugs, and for his commitment to changing harmful drug policies. He concurrently served as a senior psychiatrist at the Massachusetts Mental Health Center in Boston, Massachusetts, for 40 years. Grinspoon was a fellow of the American Association for the Advancement of Science and the American Psychiatric Association. He was founding editor of The American Psychiatric Association Annual Review and Harvard Mental Health Letter. Grinspoon was editor of Harvard Mental Health Letter for fifteen years.

The Drug Addiction Treatment Act of 2000, Title XXXV, Section 3502 of the Children's Health Act, permits physicians who meet certain qualifications to treat opioid addiction with Schedule III, IV, and V narcotic medications that have been specifically approved by the Food and Drug Administration for that indication.

<span class="mw-page-title-main">Charlie Baker</span> American businessman & politician (born 1956)

Charles Duane Baker Jr. is an American businessman and politician who is the current president of the National Collegiate Athletic Association. A member of the Republican Party, he served as the 72nd governor of Massachusetts from 2015 to 2023, and held two cabinet positions under two previous governors of Massachusetts. He also served for ten years as the CEO of Harvard Pilgrim Health Care.

<span class="mw-page-title-main">Medical cannabis in the United States</span> Use of cannabis for medical purposes in the United States

In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.

<span class="mw-page-title-main">Mark S. Gold</span>

Mark S. Gold is an American physician, professor, author, and researcher on the effects of opioids, cocaine, tobacco, and other drugs as well as food on the brain and behavior. He is married to Janice Finn Gold.

<span class="mw-page-title-main">Michael Botticelli</span> American public health official

Michael P. Botticelli is an American public health official who served as the director of the White House Office of National Drug Control Policy (ONDCP) from March 2014 until the end of President Obama's term. He was named acting director after the resignation of Gil Kerlikowske, and received confirmation from the United States Senate in February 2015. Prior to joining ONDCP, he worked in the Massachusetts Department of Public Health. Following completion of his service as ONDCP Director, he became the executive director of the Grayken Center for Addiction Medicine at the Boston Medical Center.

<span class="mw-page-title-main">2012 Massachusetts Question 3</span> Ballot measure in Massachusetts legalizing medical marijuana

The Massachusetts Medical Marijuana Initiative, appeared as the third question on the state's 2012 ballot as an indirect initiated state statute. The measure allows cannabis to be used for medical purposes in the state. The initiative—backed by the American Civil Liberties Union, the Massachusetts Patient Advocacy Alliance, and the Committee for Compassionate Medicine—was filed with proponents turning in the required signatures to the Massachusetts Attorney General's office by the August 3, 2011 deadline. Those signatures were needed for the required ten qualified voters who submitted the original petition to put forward the full text of the law they want enacted. The initiative passed with support from 63% of state voters.

David L. Nathan is an American psychiatrist, writer, and founder and past president of Doctors for Cannabis Regulation. Best known for his advocacy of cannabis legalization, he has also published research in the academic and lay press on a range of other topics, including archeology, numismatics, the history of animation and early American football.

Doctors for Drug Policy Reform, or D4DPR is a 501(c)(3) non-profit organization that serves as a global voice for licensed health professionals and scientists advocating for evidence-based drug policies and best practices that advance public health, reduce stigma, and minimize harm. D4DPR leverage the expertise, compassion, and influence of licensed health professionals to enact changes in drug policy necessary to improve public health, human rights, social justice, and consumer protections. D4DPR, formerly DFCR, was founded in 2015 by David L. Nathan. In 2021, Dr. Bryon Adinoff, an addictionologist, researcher, and editor-in-chief of the American Journal of Drug and Alcohol Abuse succeeded Nathan to become D4DPR's second president.

Chinazo D. Opia Cunningham is a physician, researcher, and Professor of Medicine at Albert Einstein College of Medicine in New York City. She is also the Director of Diversity Affairs for the Department of Medicine. She worked on the frontlines during the HIV/AIDS crisis in San Francisco and in 2020 began working on the frontlines of the Coronavirus disease 2019 (COVID-19) pandemic in New York City. She also specializes in treating patients with addiction, overseeing a network using buprenorphine to treat people with opioid addiction.

John F. Kelly is an American-based researcher and professor of addiction medicine at Harvard Medical School. He is the Founder and Director of the Massachusetts General Hospital Recovery Research Institute, Associate Director of the MGH Center for Addiction Medicine, and Program Director of the MGH Addiction Recovery Management Service.

<span class="mw-page-title-main">Scott Hadland</span> American physician and scientist

Scott E. Hadland is a Canadian-American physician and scientist who serves as a pediatrician, and addiction specialist at Massachusetts General Hospital and Harvard Medical School, where he is the Chief of the Division of Adolescent and Young Adult Medicine. He previously served as an addiction specialist at the Grayken Center for Addiction at Boston Medical Center.

References

  1. "Free Refills: A Doctor Confronts His Addiction by Peter Grinspoon". goodreads.com. Retrieved 2019-05-27.
  2. "Peter Grinspoon". C-SPAN.org. Retrieved 2019-05-27.
  3. Peter Grinspoon (5 June 2016). "Up to 15% of doctors are drug addicts. I was one of them - Los Angeles Times". Los Angeles Times . Retrieved 2019-05-27.
  4. "Peter Grinspoon, MD, Author at Harvard Health Blog - Harvard Health Publishing". health.harvard.edu. Retrieved 2019-05-27.
  5. "The DFCR Leadership Team |". dfcr.org. Retrieved 2019-05-27.
  6. "PEOPLE.com". people.com. Retrieved 2019-05-27.
  7. Edith Zimmerman (12 October 2018). "Are Addictive Personalities Real?". thecut.com. Retrieved 2019-05-27.
  8. "A doctor talks physicians and their addictions". The Boston Globe. Retrieved 2019-05-27.
  9. Grinspoon, Lester (28 July 1987). "Cancer Patients Should Get Marijuana". The New York Times. Retrieved 2019-05-27.
  10. "The Washington Post". washingtonpost.com. Retrieved 2019-05-27.
  11. "Resources & Support | A.R.T." americanrepertorytheater.org. Retrieved 2019-05-27.
  12. "'Resilient' showcases Bostonians' opioid recovery – Harvard Gazette". news.harvard.edu. 12 September 2018. Retrieved 2019-05-27.